Leptin is associated with vascular endothelial function in overweight patients with type 2 diabetes

Cardiovascular Diabetology

Volumn 13, Issue 1, 2014, Pages

  Morioka, Tomoaki ^a   Emoto, Masanori ^a   Yamazaki, Yuko ^a   Kawano, Naoya ^a   Imamura, Satoshi ^a   Numaguchi, Ryutaro ^a   Urata, Hiromi ^a   Motoyama, Koka ^a   Mori, Katsuhito ^a   Fukumoto, Shinya ^a   Koyama, Hidenori ^b   Shoji, Tetsuo ^c   Inaba, Masaaki ^a  

^a Departments of Metabolism Endocrinology and Molecular Medicine   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

^c OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Endothelial function; Leptin; Overweight; Type 2 diabetes

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; BODY MASS; BRACHIAL ARTERY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROTEIN BLOOD LEVEL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; VASCULAR ENDOTHELIUM; VERY ELDERLY; WAIST CIRCUMFERENCE; WAIST HIP RATIO; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LEPTIN; MALE; MIDDLE AGED; OVERWEIGHT;

EID: 84892405955     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-13-10     Document Type: Article

References (52)

1. Beltowski J. Leptin and atherosclerosis. Atherosclerosis 2006, 189(1):47-60. 10.1016/j.atherosclerosis.2006.03.003, 16580676.
2. Guzik TJ, Mangalat D, Korbut R. Adipocytokines - novel link between inflammation and vascular function?. J Physiol Pharmacol 2006, 57(4):505-528.
3. Ahima RS, Flier JS. Leptin. Annu Rev Physiol 2000, 62:413-437. 10.1146/annurev.physiol.62.1.413, 10845097.
4. Dubey L, Hesong Z. Role of leptin in atherogenesis. Exp Clin Cardiol 2006, 11(4):269-275. 2274849, 18651016.
5. Soderberg S, Ahren B, Jansson JH, Johnson O, Hallmans G, Asplund K, Olsson T. Leptin is associated with increased risk of myocardial infarction. J Intern Med 1999, 246(4):409-418. 10.1046/j.1365-2796.1999.00571.x, 10583712.
6. Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A, Sattar N. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 2001, 104(25):3052-3056. 10.1161/hc5001.101061, 11748099.
7. Tomiyama H, Yamashina A. Non-invasive vascular function tests: their pathophysiological background and clinical application. Circ J 2010, 74(1):24-33. 10.1253/circj.CJ-09-0534, 19920359.
8. Kimura K, Tsuda K, Baba A, Kawabe T, Boh-oka S, Ibata M, Moriwaki C, Hano T, Nishio I. Involvement of nitric oxide in endothelium-dependent arterial relaxation by leptin. Biochem Biophys Res Commun 2000, 273(2):745-749. 10.1006/bbrc.2000.3005, 10873674.
9. Lembo G, Vecchione C, Fratta L, Marino G, Trimarco V, D'Amati G, Trimarco B. Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes 2000, 49(2):293-297. 10.2337/diabetes.49.2.293, 10868946.
10. Nakagawa K, Higashi Y, Sasaki S, Oshima T, Matsuura H, Chayama K. Leptin causes vasodilation in humans. Hypertens Res 2002, 25(2):161-165. 10.1291/hypres.25.161, 12047029.
11. Matsuda K, Teragawa H, Fukuda Y, Nakagawa K, Higashi Y, Chayama K. Leptin causes nitric-oxide independent coronary artery vasodilation in humans. Hypertens Res 2003, 26(2):147-152. 10.1291/hypres.26.147, 12627874.
12. Beltowski J, Wojcicka G, Jamroz-Wisniewska A, Marciniak A. Resistance to acute NO-mimetic and EDHF-mimetic effects of leptin in the metabolic syndrome. Life Sci 2009, 85(15-16):557-567.
13. Korda M, Kubant R, Patton S, Malinski T. Leptin-induced endothelial dysfunction in obesity. Am J Physiol Heart Circ Physiol 2008, 295(4):H1514-1521. 10.1152/ajpheart.00479.2008, 2593507, 18689498.
14. Knudson JD, Dincer UD, Zhang C, Swafford AN, Koshida R, Picchi A, Focardi M, Dick GM, Tune JD. Leptin receptors are expressed in coronary arteries, and hyperleptinemia causes significant coronary endothelial dysfunction. Am J Physiol Heart Circ Physiol 2005, 289(1):H48-56. 10.1152/ajpheart.01159.2004, 15749744.
15. Sundell J, Huupponen R, Raitakari OT, Nuutila P, Knuuti J. High serum leptin is associated with attenuated coronary vasoreactivity. Obes Res 2003, 11(6):776-782. 10.1038/oby.2003.108, 12805399.
16. Gonzalez M, Lind L, Soderberg S. Leptin and endothelial function in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Atherosclerosis 2013, 228(2):485-490. 10.1016/j.atherosclerosis.2013.03.018, 23591414.
17. Cosentino F, Luscher TF. Endothelial dysfunction in diabetes mellitus. J Cardiovasc Pharmacol 1998, 32(Suppl 3):S54-61.
18. American Diabetes Association Standards of medical care in diabetes--2013. Diabetes Care 2013, 1(36 Suppl 1):11-66. American Diabetes Association.
19. Yamazaki Y, Emoto M, Morioka T, Kawano N, Lee E, Urata H, Tsuchikura S, Motoyama K, Mori K, Fukumoto S, et al. Clinical impact of the leptin to soluble leptin receptor ratio on subclinical carotid atherosclerosis in patients with type 2 diabetes. J Atheroscler Thromb 2013, 20(2):186-194. 10.5551/jat.14662, 23124060.
20. Golledge J, Clancy P, Jamrozik K, Norman PE. Obesity, adipokines, and abdominal aortic aneurysm: health in men study. Circulation 2007, 116(20):2275-2279. 10.1161/CIRCULATIONAHA.107.717926, 17967974.
21. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International brachial arteryreactivity task force. J Am Coll Cardiol 2002, 39(2):257-265. 10.1016/S0735-1097(01)01746-6, 11788217.
22. Inoue T, Matsuoka H, Higashi Y, Ueda S, Sata M, Shimada KE, Ishibashi Y, Node K. Flow-mediated vasodilation as a diagnostic modality for vascular failure. Hypertens Res 2008, 31(12):2105-2113. 10.1291/hypres.31.2105, 19139600.
23. Kawano N, Emoto M, Mori K, Yamazaki Y, Urata H, Tsuchikura S, Motoyama K, Morioka T, Fukumoto S, Shoji T, et al. Association of endothelial and vascular smooth muscle dysfunction with cardiovascular risk factors, vascular complications, and subclinical carotid atherosclerosis in type 2 diabetic patients. J Atheroscler Thromb 2012, 19(3):276-284. 10.5551/jat.10629, 22146236.
24. Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, Kajikawa M, Matsumoto T, Hidaka T, Kihara Y, et al. Nitroglycerine-induced vasodilation for assessment of vascular function: a comparison with flow-mediated vasodilation. Arterioscler Thromb Vasc Biol 2013, 33(6):1401-1408. 10.1161/ATVBAHA.112.300934, 23520168.
25. Tomiyama H, Higashi Y, Takase B, Node K, Sata M, Inoue T, Ishibashi Y, Ueda S, Shimada K, Yamashina A. Relationships among hyperuricemia, metabolic syndrome, and endothelial function. Am J Hypertens 2011, 24(7):770-774. 10.1038/ajh.2011.55, 21490690.
26. Adams MR, Robinson J, McCredie R, Seale JP, Sorensen KE, Deanfield JE, Celermajer DS. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol 1998, 32(1):123-127. 10.1016/S0735-1097(98)00206-X, 9669259.
27. Koh KK, Han SH, Oh PC, Shin EK, Quon MJ. Combination therapy for treatment or prevention of atherosclerosis: focus on the lipid-RAAS interaction. Atherosclerosis 2010, 209(2):307-313. 10.1016/j.atherosclerosis.2009.09.007, 2962413, 19800624.
28. Tomiyama H, Matsumoto C, Yamada J, Teramoto T, Abe K, Ohta H, Kiso Y, Kawauchi T, Yamashina A. The relationships of cardiovascular disease risk factors to flow-mediated dilatation in Japanese subjects free of cardiovascular disease. Hypertens Res 2008, 31(11):2019-2025. 10.1291/hypres.31.2019, 19098373.
29. Vlachopoulos C, Manesis E, Baou K, Papatheodoridis G, Koskinas J, Tiniakos D, Aznaouridis K, Archimandritis A, Stefanadis C. Increased arterial stiffness and impaired endothelial function in nonalcoholic Fatty liver disease: a pilot study. Am J Hypertens 2010, 23(11):1183-1189. 10.1038/ajh.2010.144, 20634799.
30. Mancini F, Cianciosi A, Reggiani GM, Facchinetti F, Battaglia C, de Aloysio D. Endothelial function and its relationship to leptin, homocysteine, and insulin resistance in lean and overweight eumenorrheic women and PCOS patients: a pilot study. Fertil Steril 2009, 91(6):2537-2544. 10.1016/j.fertnstert.2008.03.023, 18462732.
31. Narita K, Murata T, Hamada T, Kosaka H, Sudo S, Mizukami K, Yoshida H, Wada Y. Associations between trait anxiety, insulin resistance, and atherosclerosis in the elderly: a pilot cross-sectional study. Psychoneuroendocrinology 2008, 33(3):305-312. 10.1016/j.psyneuen.2007.11.013, 18178323.
32. Golledge J, Leicht AS, Crowther RG, Glanville S, Clancy P, Sangla KS, Spinks WL, Quigley F. Determinants of endothelial function in a cohort of patients with peripheral artery disease. Cardiology 2008, 111(1):51-56. 10.1159/000113428, 18239393.
33. Gupta AK, Johnson WD, Johannsen D, Ravussin E. Cardiovascular risk escalation with caloric excess: a prospective demonstration of the mechanics in healthy adults. Cardiovasc Diabetol 2013, 12:23. 10.1186/1475-2840-12-23, 3598491, 23347533.
34. Melikian N, Wheatcroft SB, Ogah OS, Murphy C, Chowienczyk PJ, Wierzbicki AS, Sanders TA, Jiang B, Duncan ER, Shah AM, et al. Asymmetric dimethylarginine and reduced nitric oxide bioavailability in young Black African men. Hypertension 2007, 49(4):873-877. 10.1161/01.HYP.0000258405.25330.80, 17261643.
35. Oflaz H, Ozbey N, Mantar F, Genchellac H, Mercanoglu F, Sencer E, Molvalilar S, Orhan Y. Determination of endothelial function and early atherosclerotic changes in healthy obese women. Diabetes Nutr Metab 2003, 16(3):176-181.
36. Saarikoski LA, Huupponen RK, Viikari JS, Marniemi J, Juonala M, Kahonen M, Raitakari OT. Adiponectin is related with carotid artery intima-media thickness and brachial flow-mediated dilatation in young adults-the cardiovascular risk in young Finns study. Ann Med 2010, 42(8):603-611. 10.3109/07853890.2010.514284, 20839916.
37. Singhal A, Farooqi IS, Cole TJ, O'Rahilly S, Fewtrell M, Kattenhorn M, Lucas A, Deanfield J. Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease?. Circulation 2002, 106(15):1919-1924. 10.1161/01.CIR.0000033219.24717.52, 12370213.
38. Varady KA, Bhutani S, Klempel MC, Phillips SA. Improvements in vascular health by a low-fat diet, but not a high-fat diet, are mediated by changes in adipocyte biology. Nutr J 2011, 10:8. 10.1186/1475-2891-10-8, 3032663, 21251283.
39. Mohler ER, Sibley AA, Stein R, Davila-Roman V, Wyatt H, Badellino K, Rader DJ, Klein S, Foster GD. Endothelial function and weight loss: comparison of low-carbohydrate and low-fat diets. Obesity (Silver Spring) 2013, 21(3):504-509. 10.1002/oby.20055, 3630284, 23404949.
40. Klempel MC, Kroeger CM, Norkeviciute E, Goslawski M, Phillips SA, Varady KA. Benefit of a low-fat over high-fat diet on vascular health during alternate day fasting. Nutr Diabetes 2013, 3:e71. 10.1038/nutd.2013.14, 3671747, 23712283.
41. Mavri A, Poredos P, Suran D, Gaborit B, Juhan-Vague I. Effect of diet-induced weight loss on endothelial dysfunction: early improvement after the first week of dieting. Heart Vessels 2011, 26(1):31-38. 10.1007/s00380-010-0016-1, 20922535.
42. Fruhbeck G. Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes 1999, 48(4):903-908. 10.2337/diabetes.48.4.903, 10102710.
43. Benkhoff S, Loot AE, Pierson I, Sturza A, Kohlstedt K, Fleming I, Shimokawa H, Grisk O, Brandes RP, Schroder K. Leptin potentiates endothelium-dependent relaxation by inducing endothelial expression of neuronal NO synthase. Arterioscler Thromb Vasc Biol 2012, 32(7):1605-1612. 10.1161/ATVBAHA.112.251140, 22580898.
44. Momin AU, Melikian N, Shah AM, Grieve DJ, Wheatcroft SB, John L, El Gamel A, Desai JB, Nelson T, Driver C, et al. Leptin is an endothelial-independent vasodilator in humans with coronary artery disease: evidence for tissue specificity of leptin resistance. Eur Heart J 2006, 27(19):2294-2299. 10.1093/eurheartj/ehi831, 16543250.
45. Brook RD, Bard RL, Bodary PF, Eitzman DT, Rajagopalan S, Sun Y, Depaoli AM. Blood pressure and vascular effects of leptin in humans. Metab Syndr Relat Disord 2007, 5(3):270-274. 10.1089/met.2006.0023, 18370781.
46. Jung CH, Kim BY, Kim CH, Kang SK, Jung SH, Mok JO. Association of serum adipocytokine levels with cardiac autonomic neuropathy in type 2 diabetic patients. Cardiovasc Diabetol 2012, 11:24. 10.1186/1475-2840-11-24, 3353195, 22413919.
47. Beltowski J. Leptin and the regulation of endothelial function in physiological and pathological conditions. Clin Exp Pharmacol Physiol 2012, 39(2):168-178. 10.1111/j.1440-1681.2011.05623.x, 21973116.
48. Chiu FH, Chuang CH, Li WC, Weng YM, Fann WC, Lo HY, Sun C, Wang SH. The association of leptin and C-reactive protein with the cardiovascular risk factors and metabolic syndrome score in Taiwanese adults. Cardiovasc Diabetol 2012, 11:40. 10.1186/1475-2840-11-40, 3471043, 22533665.
49. Schinzari F, Tesauro M, Rovella V, Di Daniele N, Mores N, Veneziani A, Cardillo C. Leptin stimulates both endothelin-1 and nitric oxide activity in lean subjects but not in patients with obesity-related metabolic syndrome. J Clin Endocrinol Metab 2013, 98(3):1235-1241. 10.1210/jc.2012-3424, 23372172.
50. Martin SS, Qasim A, Reilly MP. Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J Am Coll Cardiol 2008, 52(15):1201-1210. 10.1016/j.jacc.2008.05.060, 18926322.
51. Rodriguez A, Fortuno A, Gomez-Ambrosi J, Zalba G, Diez J, Fruhbeck G. The inhibitory effect of leptin on angiotensin II-induced vasoconstriction in vascular smooth muscle cells is mediated via a nitric oxide-dependent mechanism. Endocrinology 2007, 148(1):324-331. 10.1210/en.2006-0940, 17038553.
52. Quercioli A, Pataky Z, Montecucco F, Carballo S, Thomas A, Staub C, Di Marzo V, Vincenti G, Ambrosio G, Ratib O, et al. Coronary vasomotor control in obesity and morbid obesity: contrasting flow responses with endocannabinoids, leptin, and inflammation. JACC Cardiovasc Imaging 2012, 5(8):805-815. 10.1016/j.jcmg.2012.01.020, 22897994.